Thermo Fisher Scientific Inc (TMO)
541.45
-5.80
(-1.06%)
USD |
NYSE |
Apr 18, 16:00
541.45
0.00 (0.00%)
After-Hours: 20:00
Thermo Fisher Scientific Price to Book Value: 4.418 for April 18, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 17, 2024 | 4.465 |
| April 16, 2024 | 4.525 |
| April 15, 2024 | 4.552 |
| April 12, 2024 | 4.612 |
| April 11, 2024 | 4.688 |
| April 10, 2024 | 4.681 |
| April 09, 2024 | 4.807 |
| April 08, 2024 | 4.722 |
| April 05, 2024 | 4.728 |
| April 04, 2024 | 4.656 |
| April 03, 2024 | 4.700 |
| April 02, 2024 | 4.663 |
| April 01, 2024 | 4.711 |
| March 28, 2024 | 4.742 |
| March 27, 2024 | 4.727 |
| March 26, 2024 | 4.641 |
| March 25, 2024 | 4.680 |
| March 22, 2024 | 4.757 |
| March 21, 2024 | 4.766 |
| March 20, 2024 | 4.733 |
| March 19, 2024 | 4.754 |
| March 18, 2024 | 4.733 |
| March 15, 2024 | 4.766 |
| March 14, 2024 | 4.772 |
| March 13, 2024 | 4.841 |
| Date | Value |
|---|---|
| March 12, 2024 | 4.873 |
| March 11, 2024 | 4.891 |
| March 08, 2024 | 4.876 |
| March 07, 2024 | 4.876 |
| March 06, 2024 | 4.826 |
| March 05, 2024 | 4.770 |
| March 04, 2024 | 4.746 |
| March 01, 2024 | 4.702 |
| February 29, 2024 | 4.652 |
| February 28, 2024 | 4.667 |
| February 27, 2024 | 4.619 |
| February 26, 2024 | 4.598 |
| February 23, 2024 | 4.608 |
| February 22, 2024 | 4.573 |
| February 21, 2024 | 4.511 |
| February 20, 2024 | 4.472 |
| February 16, 2024 | 4.470 |
| February 15, 2024 | 4.476 |
| February 14, 2024 | 4.473 |
| February 13, 2024 | 4.394 |
| February 12, 2024 | 4.462 |
| February 09, 2024 | 4.494 |
| February 08, 2024 | 4.495 |
| February 07, 2024 | 4.506 |
| February 06, 2024 | 4.571 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.431
Minimum
Mar 23 2020
6.774
Maximum
Dec 30 2021
4.973
Average
4.919
Median
Price to Book Value Benchmarks
| Fonar Corp | 0.6602 |
| XWELL Inc | 0.4504 |
| ProPhase Labs Inc | 1.988 |
| Applied DNA Sciences Inc | 1.350 |
| Veracyte Inc | 1.381 |
Price to Book Value Related Metrics
| PE Ratio | 35.05 |
| PS Ratio | 4.902 |
| Price to Free Cash Flow | 30.33 |
| Price | 541.45 |
| Earnings Yield | 2.85% |
| Market Cap | 206.46B |
| Operating PE Ratio | 28.71 |
| Normalized PE Ratio | 32.65 |